Mechanistic investigations of HIV restriction by Serincs
Serincs 限制 HIV 的机制研究
基本信息
- 批准号:10360510
- 负责人:
- 金额:$ 3.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsBiologicalBiological AssayBullaCCR5 geneCell membraneCellsComplementCryo-electron tomographyCryoelectron MicroscopyDevelopmentFamilyFetusFluorescence MicroscopyFreezingHIVHIV BuddingHIV InfectionsHumanImageIndividualInfantInfectionInvestigationKineticsLeadMaternal-Fetal ExchangeMembraneMembrane FusionMembrane LipidsMembrane ProteinsModelingMolecular ConformationMothersPlacentaPlasma CellsProcessProtein IsoformsProteinsResolutionSpeedStructureTechniquesTestingTimeTissuesTomogramVertical Disease TransmissionVesicleViralVirusVirus Replicationbaseblocking factordesignfetal bloodin uteromembrane modelnovelnovel therapeuticsparticlepathogenpreventreceptortheoriestransmission process
项目摘要
PROJECT SUMMARY: The placenta forms a physical barrier to HIV transmission by
separating maternal and fetal blood and a functional barrier by expressing a plethora of
restriction factors to inhibit viral replication. However, vertical transmission of HIV does occur
in utero and shows that these defenses are imperfect. This is consistent with the recently
described viral restriction factor, Serinc, which is highly expressed in the placenta and can
incorporate into budding viral particles to inhibit their ability to infect. However, Serinc is an
imperfect restriction factor as it is inactivated by the viral accessory protein, Nef, and some
sequences of the HIV surface protein, Env. We plan to study the mechanism of how Serinc
restricts HIV infection to gain a better understanding of host-pathogen interactions
occurring in the placenta and with the hope of enabling the development of novel anti-
virals that can exploit the same viral weakness as Serinc but are not susceptible to the same
pitfalls.
Serincs are a family of 5 human plasma membrane proteins expressed in select tissues. Isoforms
Serinc3 and Serinc5 restrict HIV proliferation while Serinc2 incorporates into viral particles but does not
restrict. The exact mechanism by which Serinc3 and 5 reduce infectivity is incompletely understood but is
known to block infection at a step before cell entry. Two major theories have emerged: 1) Serinc
inactivates Env by causing changes to the conformation and distribution of Env trimers in the viral
particle or 2) Serinc slows or disrupts membrane fusion of the virus with the host cell plasma membrane.
In this study, we will take advantage of the development of plasma membrane “blebs” as a model for viral
membrane fusion to test the relative merits of two proposed mechanisms of Serinc. We will assess Serinc-
containing or -lacking HIV pseudoviruses for changes in structure and distribution of Env by cryo-
electron tomography and subtomogram averaging (aim 1). We will also assess whether Serincs block
membrane fusion by observing HIV pseudoviruses containing or lacking Serincs as they fuse to bleb
model membranes with high resolution cryo-electron tomography snapshots (aim 2.1) and higher
throughput fluorescence microscopy single-particle viral fusion assays (aim 2.2). Preliminary results
show Serinc3 and Serinc5 block membrane fusion by disrupting fusion pore opening but do not affect
Env distribution or the speed at which viral particles undergo membrane fusion. With these two aims, we
will be able to discriminate between competing hypotheses about the mechanism of Serinc restriction of
HIV infection, gain a better understanding of how HIV transmits in the placenta, and potentially enable
the development of new anti-virals.
项目摘要:胎盘通过以下方式形成了艾滋病毒传播的物理屏障:
通过表达大量的蛋白来分离母体和胎儿的血液以及功能屏障
抑制病毒复制的限制因素。然而,艾滋病毒的垂直传播确实存在
在子宫内并表明这些防御是不完善的。这与近期的情况相符
描述了病毒限制因子 Serinc,它在胎盘中高度表达,并且可以
掺入出芽的病毒颗粒中以抑制其感染能力。然而,Serinc 是一个
不完美的限制因子,因为它被病毒辅助蛋白 Nef 和一些病毒失活
HIV 表面蛋白 Env 的序列。我们计划研究 Serinc 的机制
限制艾滋病毒感染,以更好地了解宿主与病原体的相互作用
发生在胎盘中,希望能够开发出新型抗
可以利用与 Serinc 相同的病毒弱点,但不易受到相同病毒的影响
陷阱。
Serinc 是在特定组织中表达的 5 种人类质膜蛋白家族。同工型
Serinc3和Serinc5限制HIV增殖,而Serinc2融入病毒颗粒但不
限制。 Serinc3 和 5 降低传染性的确切机制尚不完全清楚,但已被证实
已知可在进入细胞之前的步骤阻止感染。出现了两种主要理论:1)Serinc
通过改变病毒中 Env 三聚体的构象和分布来灭活 Env
颗粒或2)丝氨酸减缓或破坏病毒与宿主细胞质膜的膜融合。
在这项研究中,我们将利用质膜“泡”的发展作为病毒模型
膜融合来测试 Serinc 的两种提议机制的相对优点。我们将评估 Serinc-
含有或缺乏 HIV 假病毒,通过冷冻改变 Env 的结构和分布
电子断层扫描和次断层扫描平均(目标 1)。我们还将评估 Serincs 是否会阻止
通过观察含有或缺乏丝氨酸的 HIV 假病毒与泡融合时的膜融合
具有高分辨率冷冻电子断层扫描快照(目标 2.1)及更高版本的模型膜
高通量荧光显微镜单颗粒病毒融合测定(目标 2.2)。初步结果
显示 Serinc3 和 Serinc5 通过破坏融合孔开放来阻止膜融合,但不影响
包膜分布或病毒颗粒进行膜融合的速度。带着这两个目标,我们
将能够区分有关 Serinc 限制机制的相互竞争的假设
HIV 感染,更好地了解 HIV 如何在胎盘中传播,并有可能使
新型抗病毒药物的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amanda Elizabeth Ward其他文献
Amanda Elizabeth Ward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amanda Elizabeth Ward', 18)}}的其他基金
Mechanistic investigations of HIV restriction by Serincs
Serincs 限制 HIV 的机制研究
- 批准号:
9927150 - 财政年份:2020
- 资助金额:
$ 3.38万 - 项目类别:
相似海外基金
NSF/BIO-DFG: Biological Fe-S intermediates in the synthesis of nitrogenase metalloclusters
NSF/BIO-DFG:固氮酶金属簇合成中的生物 Fe-S 中间体
- 批准号:
2335999 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Large Language Models for Biological Discoveries (LLMs4Bio)
合作研究:会议:生物发现的大型语言模型 (LLMs4Bio)
- 批准号:
2411529 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Large Language Models for Biological Discoveries (LLMs4Bio)
合作研究:会议:生物发现的大型语言模型 (LLMs4Bio)
- 批准号:
2411530 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
Collaborative Research: NSF-ANR MCB/PHY: Probing Heterogeneity of Biological Systems by Force Spectroscopy
合作研究:NSF-ANR MCB/PHY:通过力谱探测生物系统的异质性
- 批准号:
2412551 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
Elucidating mechanisms of biological hydrogen conversion through model metalloenzymes
通过模型金属酶阐明生物氢转化机制
- 批准号:
2419343 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
Collaborative Research: The Interplay of Water Condensation and Fungal Growth on Biological Surfaces
合作研究:水凝结与生物表面真菌生长的相互作用
- 批准号:
2401507 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
DESIGN: Driving Culture Change in a Federation of Biological Societies via Cohort-Based Early-Career Leaders
设计:通过基于队列的早期职业领袖推动生物协会联盟的文化变革
- 批准号:
2334679 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
REU Site: Modeling the Dynamics of Biological Systems
REU 网站:生物系统动力学建模
- 批准号:
2243955 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Standard Grant
Defining the biological boundaries to sustain extant life on Mars
定义维持火星现存生命的生物边界
- 批准号:
DP240102658 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Discovery Projects
Advanced Multiscale Biological Imaging using European Infrastructures
利用欧洲基础设施进行先进的多尺度生物成像
- 批准号:
EP/Y036654/1 - 财政年份:2024
- 资助金额:
$ 3.38万 - 项目类别:
Research Grant














{{item.name}}会员




